Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-01-18
2011-01-18
Bunner, Bridget E (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S142100, C424S130100, C512S012000, C530S387100
Reexamination Certificate
active
07871619
ABSTRACT:
Ligands of CCX-CKR2 and the biological role of CCX-CKR2 in cancer is described.
REFERENCES:
patent: 4166452 (1979-09-01), Generales, Jr.
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 4927838 (1990-05-01), Guthrie et al.
patent: 5994519 (1999-11-01), Osbourn et al.
patent: 6084075 (2000-07-01), Lind et al.
patent: 6140064 (2000-10-01), Loetscher et al.
patent: 6156520 (2000-12-01), Inglese et al.
patent: 6180336 (2001-01-01), Osbourn et al.
patent: 6184358 (2001-02-01), Loetscher et al.
patent: 6197069 (2001-03-01), Poste et al.
patent: 6329159 (2001-12-01), Andrew et al.
patent: 6365356 (2002-04-01), Gershengorn
patent: 6448054 (2002-09-01), Poznansky et al.
patent: 6537764 (2003-03-01), Gerard et al.
patent: 2002/0004215 (2002-01-01), Osbourn et al.
patent: 2002/0025536 (2002-02-01), Gyuris et al.
patent: 2002/0034757 (2002-03-01), Cubicciotti
patent: 2002/0037539 (2002-03-01), Qin et al.
patent: 2002/0048786 (2002-04-01), Rosen et al.
patent: 2002/0061599 (2002-05-01), Elling et al.
patent: 2002/0061834 (2002-05-01), Rosen et al.
patent: 2002/0064770 (2002-05-01), Nestor, Jr. et al.
patent: 2002/0076710 (2002-06-01), Papsidero et al.
patent: 0897980 (1999-02-01), None
patent: WO 98/11218 (1998-03-01), None
patent: WO 98/14480 (1998-04-01), None
patent: WO 99/50461 (1999-10-01), None
Ebert, Lisa M. et al.; “Coregulation of CXC Chemokine Receptor and CD4 Expression on T Lymphocytes During Allogeneic Activation”; 2001,Journal of Immunology, vol. 166, No. 8, pp. 4870-4878.
Abdel-Magid, Ahmed F. et al.; “Reductive Amination of Aldehydes and Ketones by Using Sodium Triacetoxyborohydride”;Tetrahedron Lett., 1990, vol. 31, pp. 5595-5598.
Babcock, Gregory J. et al.; “Ligand Binding Characteristics of CXCR4 Incorporated into Paramagnetic Proteoliposomes”;The Journal of Biological Chemistry2001, vol. 276 No. 42, pp. 38433-38440.
Baribaud, Frederic et al.; “Antigenically Distinct Conformations of CXCR4”;Journal of Virology2001, vol. 75 No. 19, pp. 8957-8967.
Barney, Charlotte L. et al.; “A Convenient Synthesis of Hindered Amines and α-Trifluoromethylamines from Ketones”;Tetrahedron Lett., 1990, vol. 31, pp. 5547-5550.
Bertolini, Francesco et al.; “Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma”;Blood, 2000, vol. 96, No. 1, pp. 282-287.
Bertolini, Francesco et al.; “CXCR4 Neutralization, a Novel Therapeutic Approach for Non-Hodgkin's Lymphoma”;Cancer Research,2002, vol. 62, pp. 3106-3112.
Cook, Jonathan S. et al.; “Characterization of the RDC1 gene which encodes the canine homolog of a proposed human VIP receptor”; 1992, FEBS Letters, vol. 300, No. 2, pp. 149-152.
Dairaghi, Daniel J.; “HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8”;The Journal of Biological Chemistry1999, vol. 274, No. 31, pp. 21569-21574.
Dragic, Tatjana; “An overview of the determinants of CCR5 and CXCR4 co-reseptor function”;Journal of General Virology2001, vol. 82, pp. 1807-1814.
Forster, Reinhold et al.; “Intracellular and Surface Expression of the HIV-1 Coreceptor CXCR4/Fusin on Various Leukocyte Subsets: Rapid Internalization and Recycling Upon Activation”;The Journal of Immunology1998, vol. 160, pp. 1522-1531.
Gerlach, Lars Ole et al.; “Molecular Interactions of Cyclam and Bicyclam Non-peptide Antagonists with the CXCR4 Chemokine Receptor”;The Journal of Biological Chemistry2001, vol. 276 No. 17, pp. 14153-14160.
Gosling, Jennifa et al.; “Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK”;The Journal of Immunology2000, pp. 2851-2856.
Gribble, Gordon, W. et al.; “Reactions of Sodium Borohydride in Acidic Media; XVI. N-Methylation of Amines with Paraformaldehyde/Trifluoroacetic Acid”;Synthesis, 1987, pp. 709-711.
Heesen, Michael et al.; “Cloning and chromosomal mapping of an orphan chemokine receptor: mouse RDC1”; 1998,Immunogenetics, vol. 47, pp. 364-370.
Kevill, Dennis N. et al.; “Correlation of the Rates of Solvolysis of Allyl and Benzyl Arenesulphonates”;Journal of Chemical Society Perkin Trans., 1984, vol. 2, pp. 717-720.
Kledal, Thomas N. et al.; “A Broad-Spectrum Chemokine Antagonist Encoded by Kaposi's Sarcoma-Associated Herpesvirus”;Science1997, vol. 277, pp. 1656-1659.
Lee, Benhur et al.; “Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function”;The Journal of Biological Chemistry1999, vol. 274 No. 14, pp. 9617-9626.
Libert, Frederick et al.; “Selective Amplification and Cloning of Four New Members of the G Protein-Coupled Receptor Family”; 1989,Science, vol. 244, No. 4904, pp. 569-572.
Libert, Frederick et al.; “Complete nucleotide sequence of a putative G protein coupled receptor: RDC7”; 1990,Nucleic Acids Research, vol. 18, No. 7, pp. 1915.
Lin, Engnian et al.; “Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2”;Proc. Natl. Acad. Sci.1998, vol. 95, pp. 8829-8834.
Liotta, Lance A.; “An attractive force in metastasis”;Nature, 2001, vol. 410, pp. 24-25.
Mattson, Ronald J. et al.; “An Improved Method for Reductive Alkylation of Amines Using Titanium (IV) Isopropoxide and Sodium Cyanoborohydride”;J. Org. Chem., 1990, vol. 55, pp. 2552-2554.
Moepps, Barbara et al.; “Two murine homologues of the human chemokine receptor CXCR4 mediating stromal cell-derived factor 1α activation of Gi2are differently expressed in vivo”;Eur. J. Immunol.1997, vol. 27, pp. 2102-2112.
Muller, Anja et al.; “Involvement of chemokine receptors in breast cancer metastasis”;Nature2001, vol. 410, pp. 50-56.
Neises, Bernhard et al.; “Simple Method for the Esterification of Carboxylic Acids”;Angew. Chem. Int. Ed. Engl., 1978, vol. 17, No. 7, pp. 522-524.
Neote, Kuldeep, et al.; “Molecular Cloning, Functional Expression, and Signaling Characteristics of a C-C Chemokine Receptor”;Cell, 1993, vol. 72, pp. 415-425.
Oppenheim, Joost J. et al.; “Properties of the Novel Proinflammatory Supergene “Intercrine” Cytokine Family”;Annu. Rev. Immunol., 1991, vol. 9, pp. 617-648.
Parolin, Cristina et al.; “Use of Murine CXCR-4 as a Second Receptor by Some T-Cell-Tropic Human Immunodeficiency Viruses”;Journal of Virology1998, vol. 72 No. 2, pp. 1652-1656.
Ponath, Paul D. et al.; “Molecular Cloning and Characterization of a Human Eotaxin Receptor Expressed Selectively on Eosinophils”;J. Exp. Med., 1996, vol. 183, pp. 2437-2448.
Power, Christine A. et al.; “Molecular Cloning and Functional Expression of a Novel CC Chemokine Receptor cDNA from a Human Basophilic Cell Line”;The Journal of Biological Chemistry, 1995, vol. 270, No. 33, pp. 19495-19500.
Pulaski, Beth A. et al.; “Cooperativity ofStaphylococcal aureusEnterotoxin B Superantigen, Major Histocompatibility Complex Class II, and CD80 for Immunotherapy of Advanced Spontaneous Metastases in a Clinically Relevant Postoperative Mouse Breast Cancer Model”;Cancer Research, 2000, vol. 60, pp. 2710-2715.
Schall, Thomas J.; “Biology of the Rantes/sis Cytokine Family”;Cytokine, 1996, vol. 3, No. 3, pp. 165-183.
Sreedharan, Sunil P. et al.; “Cloning and expression of the human vasoactive intestinal peptide receptor”; 1991,PNAS, vol. 88, pp. 4986-4990.
Watanabe, Yoshihisa et al.; “The Selective Amination of Carbonyl Compounds using Iron Pentacarbonyl”;Tetrahedron Lett.,1974, vol. 22, pp. 1879-1880.
Wegner, Scott A. et al.; “Genomic Organization and Functional Characterization of the Chemokin
Burns Jennifer M.
Howard Maureen C.
Miao Zhenhua
Schall Thomas J.
Summers Bretton
Bunner Bridget E
ChemoCentryx, Inc.
Hamud Fozia M
Townsend and Townsend / and Crew LLP
LandOfFree
Compositions and methods for detecting and treating diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for detecting and treating diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for detecting and treating diseases... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2675174